Basic Information
ATLAB Pharma Develops Antibody-Targeted Radiotherapy for Cancer. Radioimmunotherapy is a tumor-specific delivery system that uses monoclonal antibodies conjugated with radioisotopes (radioactive antibodies) to target radiation therapy to cancer cells wherever they have spread in the body, thereby extending the well-established therapeutic effects of radiation from localized tumors to metastatic cancers.